CausalSentinel

Protein Dossier — PCSK9 (Proprotein convertase subtilisin/kexin type 9)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: high cholesterol 0.277 0.0294 3.74e-21 Wald ratio 1 cis NA
Diagnoses - main ICD10: C50 Malignant neoplasm of breast 0.274 0.0859 0.00143 Wald ratio 1 cis NA
Vascular or heart problems diagnosed by doctor: Angina 0.162 0.0687 0.0186 Wald ratio 1 cis NA
Low grade serous ovarian cancer -0.592 0.258 0.0218 Wald ratio 1 cis NA
Diagnoses - main ICD10: I83 Varicose veins of lower extremities 0.173 0.0848 0.0407 Wald ratio 1 cis NA
Fractured bone site(s): Other bones 0.103 0.0564 0.0678 Wald ratio 1 cis NA
Non-cancer illness code self-reported: depression -0.12 0.0669 0.0727 Wald ratio 1 cis NA
Non-cancer illness code self-reported: anxiety or panic attacks 0.184 0.104 0.0763 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hyperthyroidism or thyrotoxicosis 0.237 0.134 0.0765 Wald ratio 1 cis NA
Eye problems or disorders: Glaucoma -0.293 0.167 0.0793 Wald ratio 1 cis NA
Non-cancer illness code self-reported: osteoporosis 0.169 0.0981 0.0844 Wald ratio 1 cis NA
Fractured or broken bones in last 5 years 0.0707 0.0417 0.09 Wald ratio 1 cis NA
…and 52 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-5231_79_3 PCSK9 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

1545 association rows across 589 traits (1493 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Low density lipoprotein cholesterol levels 3e-1364 rs11591147 62 GCST90239655 no MR -> candidate analysis
Total cholesterol levels 1e-1070 rs11591147 78 GCST90239673 no MR -> candidate analysis
Non-HDL cholesterol levels 8e-875 rs11591147 5 GCST90239667 no MR -> candidate analysis
Apolipoprotein B levels 8e-521 rs11591147 24 GCST90019496 no MR -> candidate analysis
Low-density lipoprotein levels 2e-449 rs11591147 2 GCST90662892 no MR -> candidate analysis
LDL cholesterol levels 2e-421 rs11591147 22 GCST010245 no MR -> candidate analysis
LDL cholesterol 2e-335 rs11591147 14 GCST90018961 no MR -> candidate analysis
low density lipoprotein cholesterol (LDLC, maximum, inv-norm 1e-323 rs28362286 3 GCST90475411 no MR -> candidate analysis
low density lipoprotein cholesterol (LDLC, mean, inv-norm tr 1e-323 rs28362286 3 GCST90479661 no MR -> candidate analysis
total cholesterol (mean, inv-norm transformed) 1e-287 rs28362286 3 GCST90476423 no MR -> candidate analysis
low density lipoprotein cholesterol (LDLC, minimum, inv-norm 4e-283 rs28362286 3 GCST90475419 no MR -> candidate analysis
total cholesterol (maximum, inv-norm transformed) 5e-279 rs28362286 3 GCST90476419 no MR -> candidate analysis
…and 577 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 959 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
familial hypercholesterolemia 0.859 0.737 established (curated) no MR -> candidate analysis
Hypercholesterolemia 0.923 0.925 established (curated) MR: beta=0.277, p=3.74e-21 (cis)
hypercholesterolemia, autosomal dominant, 3 0.939 established (curated) no MR -> candidate analysis
cardiovascular disorder 0.887 common-variant locus no MR -> candidate analysis
coronary artery disorder 0.907 common-variant locus no MR -> candidate analysis
metabolic disease 0.932 0.938 multi-layer: burden+GWAS (allelic-series candidate) no MR -> candidate analysis
hyperlipidemia 0.904 common-variant locus no MR -> candidate analysis
myocardial infarction 0.875 common-variant locus no MR -> candidate analysis
homozygous familial hypercholesterolemia 0.72 established (curated) no MR -> candidate analysis
Disorder of lipid metabolism 0.849 0.86 multi-layer: burden+GWAS (allelic-series candidate) no MR -> candidate analysis
atherosclerosis 0.554 common-variant locus no MR -> candidate analysis
hypercholesterolemia, familial, 1 0.92 established (curated) no MR -> candidate analysis
coronary atherosclerosis 0.868 common-variant locus no MR -> candidate analysis
myocardial ischemia 0.867 common-variant locus no MR -> candidate analysis
familial hyperlipidemia 0.852 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 14 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 2 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 2 known modulators (PCSK9 mRNA)
gnomAD constraint pLI=2.8e-18, LOEUF=1.14 — LoF-tolerant
GWAS Catalog 106 unique SNPs / 246 rows
ClinVar 1569 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance